Skip to main content

Table 4 Comparing quality of life in two different groups of patients with neoadjuvantor without radiotherapy

From: Patient’s quality of life after surgery and radiotherapy for extremity soft tissue sarcoma - a retrospective single-center study over ten years

QLQ-C30

Radiotherapy

p-value (no radio-therapy vs. neoadjuvant)

no

neo-adjuvant

(n = 31) 42%

(n = 39) 52%

Global QoL score

73.1 (65–81)

58.6 (51–66)

0.006*

Physical function score

88.1 (83–94)

68.2 (60–76)

< 0.001*

Role function score

75.2 (67–84)

52.9 (43–63)

0.002*

Emotional function score

80.1 (73–87)

65.3 (57–74)

0.022*

Cognitive function score

88.8 (83–95)

80.1 (72–88)

0.247

Social function score

87.6 (80–95)

60,9 (51–71)

< 0.001*

Fatigue score

25.9 (15–37)

43.4 (34–53)

0.023*

Pain score

22 (13–31)

42.9 (31–55)

0.016*

Insomnia score

19.3 (10–29)

25,4 (15–36)

0.505

Appetite loss score

3.2 (−0.4–6.9)

3.9 (0.47–7.2)

0.68

Nausea and vomiting score

1.6 (−0–3.5)

1.7 (− 0.3–3.8)

0.824

Constipation score

6.4 (−1.5–14)

12.2 (4–21)

0.151

Diarrhoea score

6.4 (0.6–12)

10.8 (4.3–17)

0.286

Dyspnea score

7.5 (2.3–13)

22.8 (13–33)

0.034*

Financial problems score

11.8 (2–22)

31.5 (20–44)

0.009*

  1. * statistically significant (p < 0.05). Shown as CI = Confidence interval 95% and lower/upper confidence bounds (CI (lower-upper))